Now showing items 41-50 of 53
EGFR and EGFRvIII Expression in Primary Breast Cancer and Cell Lines
(Kluwer Academic Publishers; Springer Science+Business Media, 2004-09)
EGFRvIII is a constitutively activated truncated variant of the epidermal growth factor receptor (EGFR) which has been shown to increase tumorgenicity. There are conflicting reports on the extent of EGFRvIII expression in ...
Immunologic response to cryoablation of breast cancer
(Kluwer Academic Publishers; Springer, 2005-03)
Purpose .With improvements in breast imaging and image-guided interventions, there is interest in ablative techniques for breast cancer. Cryosurgery initiates inflammation and leaves tumor-specific antigens intact, which ...
Consensus Statement: Expedition Inspiration Fund for Breast Cancer Research Meeting 2002
(Kluwer Academic Publishers; Springer Science+Business Media, 2003-03)
A Multicenter Randomized Clinical Trial Evaluating Interleukin-2 Activated Hematopoietic Stem Cell Transplantation and Post-transplant IL-2 for High Risk Breast Cancer Patients
(Kluwer Academic Publishers; Springer, 2005-09)
This Phase III randomized multicenter trial compared progression-free (PFS) and overall survival (OS) for autologous peripheral blood stem cell (aPBSC) transplantation with or without immunotherapy in high-risk breast ...
Nutritional predictors for cellular nipple aspirate fluid: Nutrition and Breast Health Study
(Kluwer Academic Publishers-Plenum Publishers; Springer, 2005-11-30)
The presence of epithelial cells in breast nipple aspirate fluid (NAF), irrespective of abnormality, has been associated with increased risk of breast cancer in previous studies. We sought to investigate whether the presence ...
Identification of cell-of-origin breast tumor subtypes in inflammatory breast cancer by gene expression profiling
(Kluwer Academic Publishers-Plenum Publishers; Springer Science+Business Media, Inc., 2006-02)
Inflammatory breast cancer (IBC) is an aggressive form of locally advanced breast cancer with high metastatic potential. Most patients have lymph node involvement at the time of diagnosis and 1/3 of the patients have distant ...